Jubilant Life Sciences Ltd.

Jubilant Life Sciences Limited, is an integrated global pharmaceutical and life sciences company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients. It also provides services in Contract Manufacturing of Sterile Injectables and Drug Discovery . The Company’s strength lies in its unique offerings of Pharmaceutical and Life Sciences products and services across the value chain. Our success is an outcome of strategic focus on the pharmaceuticals and life sciences industry, moving up the pharmaceutical value chain for products and services across geographies, constantly investing in various growth platforms and promoting a culture of innovation. We are engaged in continuous improvement of products and processes to enhance the quality of production and cost competitiveness in order to build value for our customers. Jubilant Life Sciences serves its customers globally with sales in over 100 countries and ground presence in India, North America, Europe and China. We are well recognised as a ‘Partner of Choice’ by leading life sciences companies worldwide. Jubilant has relationship with 19 of Top 20 pharmaceutical and 7 among top 10 agrochemical companies across the globe.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

RAW MATERIALS

CHEMTRADE TO SELL TWO SPECIALTY CHEMICAL BUSINESSES TO VERTELLUS

Chemtrade | September 30, 2021

news image

Chemtrade Logistics Income Fund announced that it has entered into a definitive agreement to sell its Potassium Chloride (KCl) and Vaccine Adjuvants businesses to Vertellus, a manufacturer of specialty products for various consumer goods, food and agriculture, healthcare and industrial markets, for approximately US$155 million. The transaction is expected to close during the fourth quarter of 2021 and is subject to customary closing conditions. Vertellus, a Pritzker Private ...

Read More

CHEMICAL MANAGEMENT

GINKGO BIOWORKS ANNOUNCES RESEARCH AND DEVELOPMENT COLLABORATION WITH SUMITOMO CHEMICAL TO DEVELOP MORE SUSTAINABLE BIO-BASED CHEMICALS FOR INDUSTRIES

Bioworks, Sumitomo Chemical Company Limited | June 08, 2021

news image

Ginkgo Bioworks, Inc. announced today the signing of a collaboration agreement with Sumitomo Chemical Co., Ltd., one of Japan's leading chemical companies. Ginkgo is building the industry's best horizontal platform for cell programming to serve customers from various sectors looking to develop better products. Sumitomo Chemical intends to use Ginkgo's long-standing expertise in organism engineering to significantly improve the efficiency and sustainability of an essential bio-based c...

Read More

CHEMICAL TECHNOLOGY

W. R. GRACE & CO. BUYS ALBEMARLE'S FINE CHEMISTRY SERVICES BUSINESS

Albemarle | June 03, 2021

news image

Albemarle Corporation, a global specialty chemicals industry leader, announced that it had completed the sale of its Fine Chemistry Services business to W. R. Grace & Co. for approximately $570 million, consisting of $300 million in cash. The issuance to Albemarle of preferred equity of a W. R. Grace & Co. subsidiary having an aggregate stated value of $270 million. The sale includes Albemarle's operations in Tyrone, Pennsylvania, and South Haven, Michigan. "The s...

Read More

CHEMICAL MANAGEMENT

HUNTSMAN COMPLETES THE ACQUISITION OF GABRIEL PERFORMANCE PRODUCTS, FURTHER EXPANDING ITS SPECIALTY CHEMICALS PORTFOLIO

Huntsman | January 20, 2021

news image

Huntsman Corporation (NYSE: HUN) today announced it completed the acquisition of Gabriel Performance Products (Gabriel), a North American specialty chemical manufacturer of specialty additives and epoxy curing agents for the coatings, adhesives, sealants and composite end-markets, from Audax Private Equity. Huntsman paid $250 million, subject to customary closing adjustments, in an all-cash transaction funded from available liquidity. Gabriel had 2019 revenues of approximately $106 millio...

Read More
news image

RAW MATERIALS

CHEMTRADE TO SELL TWO SPECIALTY CHEMICAL BUSINESSES TO VERTELLUS

Chemtrade | September 30, 2021

Chemtrade Logistics Income Fund announced that it has entered into a definitive agreement to sell its Potassium Chloride (KCl) and Vaccine Adjuvants businesses to Vertellus, a manufacturer of specialty products for various consumer goods, food and agriculture, healthcare and industrial markets, for approximately US$155 million. The transaction is expected to close during the fourth quarter of 2021 and is subject to customary closing conditions. Vertellus, a Pritzker Private ...

Read More
news image

CHEMICAL MANAGEMENT

GINKGO BIOWORKS ANNOUNCES RESEARCH AND DEVELOPMENT COLLABORATION WITH SUMITOMO CHEMICAL TO DEVELOP MORE SUSTAINABLE BIO-BASED CHEMICALS FOR INDUSTRIES

Bioworks, Sumitomo Chemical Company Limited | June 08, 2021

Ginkgo Bioworks, Inc. announced today the signing of a collaboration agreement with Sumitomo Chemical Co., Ltd., one of Japan's leading chemical companies. Ginkgo is building the industry's best horizontal platform for cell programming to serve customers from various sectors looking to develop better products. Sumitomo Chemical intends to use Ginkgo's long-standing expertise in organism engineering to significantly improve the efficiency and sustainability of an essential bio-based c...

Read More
news image

CHEMICAL TECHNOLOGY

W. R. GRACE & CO. BUYS ALBEMARLE'S FINE CHEMISTRY SERVICES BUSINESS

Albemarle | June 03, 2021

Albemarle Corporation, a global specialty chemicals industry leader, announced that it had completed the sale of its Fine Chemistry Services business to W. R. Grace & Co. for approximately $570 million, consisting of $300 million in cash. The issuance to Albemarle of preferred equity of a W. R. Grace & Co. subsidiary having an aggregate stated value of $270 million. The sale includes Albemarle's operations in Tyrone, Pennsylvania, and South Haven, Michigan. "The s...

Read More
news image

CHEMICAL MANAGEMENT

HUNTSMAN COMPLETES THE ACQUISITION OF GABRIEL PERFORMANCE PRODUCTS, FURTHER EXPANDING ITS SPECIALTY CHEMICALS PORTFOLIO

Huntsman | January 20, 2021

Huntsman Corporation (NYSE: HUN) today announced it completed the acquisition of Gabriel Performance Products (Gabriel), a North American specialty chemical manufacturer of specialty additives and epoxy curing agents for the coatings, adhesives, sealants and composite end-markets, from Audax Private Equity. Huntsman paid $250 million, subject to customary closing adjustments, in an all-cash transaction funded from available liquidity. Gabriel had 2019 revenues of approximately $106 millio...

Read More